Page last updated: 2024-09-05

m 16209 and Diabetes Mellitus, Adult-Onset

m 16209 has been researched along with Diabetes Mellitus, Adult-Onset in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ida, K; Kato, K; Miwa, I; Mizota, M; Murakami, N; Nakayama, K; Ohta, M; Okuda, J1
Kato, K; Miwa, I; Mizota, M; Murakami, N; Nakayama, K; Notsu, T; Ohta, M; Okuda, J1

Other Studies

2 other study(ies) available for m 16209 and Diabetes Mellitus, Adult-Onset

ArticleYear
Antihyperglycemic effects of M16209, a novel aldose reductase inhibitor, in normal and diabetic rats.
    European journal of pharmacology, 1995, Mar-24, Volume: 276, Issue:1-2

    Topics: Aldehyde Reductase; Animals; Benzofurans; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Hydantoins; Hypoglycemic Agents; Insulin; Insulin Secretion; Male; Rats; Rats, Wistar; Streptozocin

1995
Effects of M16209 on insulin secretion in isolated, perfused pancreases of normal and diabetic rats.
    European journal of pharmacology, 1995, Mar-24, Volume: 276, Issue:1-2

    Topics: Aldehyde Reductase; Animals; Benzofurans; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Hydantoins; Hypoglycemic Agents; Insulin; Insulin Secretion; Male; Pancreas; Perfusion; Potassium Channels; Rats; Rats, Wistar; Streptozocin

1995